Host and graft glial composition in a stem cell transplantation model of Parkinson’s disease
Parkinson’s disease (PD) is the second most common neurodegenerative disease, and it is known for the recognisable motor symptoms. The cause of the disease is the loss of a specific cell type in the brain, called dopaminergic (DA) neurons. Significant steps towards stem cell replacement therapy of DA neurons have been made in the last few decades. Despite that, one aspect has been quite overlooked
